Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PharmadrugLMLLF +84.00% Days Sales Outstanding is 0.00 as of Mar. 2026. The stock has 1 warning sign investors should review. Among 946 Drug Manufacturers companies, Pharmadrug ranks worse than 105708.14% on this metric.
The historical rank and industry rank for Pharmadrug's Days Sales Outstanding or its related term are showing as below:
During the past 13 years, Pharmadrug's highest Days Sales Outstanding was 1538.21. The lowest was 11.35. And the median was 14.94.
LMLLF's Days Sales Outstanding is not ranked *
in the Drug Manufacturers industry.
Industry Median: 71.955 * Ranked among companies with meaningful Days Sales Outstanding only.
Pharmadrug's Days Sales Outstanding
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
Pharmadrug (OTCPK:LMLLF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Pharmadrug Days Sales Outstanding Related Terms
Pharmadrug Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Pharmadrug's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Pharmadrug's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmadrug Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pharmadrug's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Pharmadrug's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmadrug (LMLLF) has a Days Sales Outstanding of 0.00 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Pharmadrug and its competitors. Over the past decade, Pharmadrug's Days Sales Outstanding has ranged from 11.35 to 1,538.21. According to the industry distribution chart, Pharmadrug ranks #999999 out of 946 companies in the Drug Manufacturers industry.
Is Pharmadrug's Days Sales Outstanding too high?
Pharmadrug's current Days Sales Outstanding is 0.00. Over the past 10 years, this metric has ranged from a low of 11.35 to a high of 1,538.21. Based on the distribution chart, Pharmadrug ranks #999999 out of 946 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Pharmadrug's Days Sales Outstanding compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Pharmadrug ranks #999999 out of 946 companies for Days Sales Outstanding. This places Pharmadrug in the lower half of its industry. The industry median Days Sales Outstanding is 71.96. Historically, Pharmadrug's own Days Sales Outstanding has ranged from 11.35 to 1,538.21 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.96, based on 946 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Pharmadrug and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmadrug's current Days Sales Outstanding is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmadrug stock overvalued right now?
Based on GuruFocus' analysis, Pharmadrug (LMLLF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.04, compared to a current price of $0.01 — trading 83.9% below its estimated fair value. The current Days Sales Outstanding is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Pharmadrug (LMLLF), the current Days Sales Outstanding is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The company's operations comprise of the corporate division in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMLLF has been successfully added to your 
